The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...
Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...
Dr. Wimms brings extensive industry and clinical development experience in sleep medicine innovationNEW YORK and MELBOURNE, Australia, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Inc. (Nasdaq: IXHL), (Incannex ...
ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...
The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...
Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...
ResMed is an innovation machine ... devices are the frontline and gold standard for treating sleep apnea and that these PAP devices -- CPAP APAP bilevel have the highest efficacy when used as directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback